SEC Tracker
Get the app

Possible new Kyntra Bio shares

KYNBDilution

Known so far: no new shares from the prospectus covers read · shelf room about $7.0M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $7.0M
  • One third of float $7.0M ($21.0M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $7.0M on the S-3 of Jun 28, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $21.0M public float stated as of Jun 30, 2025, $7.0M, nothing sold off it in the last 12 months. Sources: S-3 Jun 28, 2024, effective Jul 10, 2024 · public float, as of Jun 30, 2025.

What could become new Kyntra Bio (KYNB) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (4M shares, +0% from 4.0M on Jul 31, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

4.0M

Oct 2024 to Jul 2026: from 4.0M to 4.0M. Adjusted for the 1-for-25 reverse split by Jul 31, 2025: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.